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The phosphoinositide 3-kinases (PI3K/Akt) dependent signaling pathway plays an important role in cardiac function,
specifically cardiac contractility. We have reported that sepsis decreases myocardial Akt activation, which correlates
with cardiac dysfunction in sepsis. We also reported that preventing sepsis induced changes in myocardial Akt
activation ameliorates cardiovascular dysfunction. In this study we investigated the role of PI3K/Akt on
cardiomyocyte function by examining the role of PI3K/Akt-dependent signaling on [Ca2+]i, Ca
2+ transients and
membrane Ca2+ current, ICa, in cultured murine HL-1 cardiomyocytes. LY294002 (1–20 μM), a specific PI3K inhibitor,
dramatically decreased HL-1 [Ca2+]i, Ca
2+ transients and ICa. We also examined the effect of PI3K isoform specific
inhibitors, i.e. α (PI3-kinase α inhibitor 2; 2–8 nM); β (TGX-221; 100 nM) and γ (AS-252424; 100 nM), to determine the
contribution of specific isoforms to HL-1 [Ca2+]i regulation. Pharmacologic inhibition of each of the individual PI3K
isoforms significantly decreased [Ca2+]i, and inhibited Ca
2+ transients. Triciribine (1–20 μM), which inhibits AKT
downstream of the PI3K pathway, also inhibited [Ca2+]i, and Ca
2+ transients and ICa. We conclude that the PI3K/Akt
pathway is required for normal maintenance of [Ca2+]i in HL-1 cardiomyocytes. Thus, myocardial PI3K/Akt-PKB
signaling sustains [Ca2+]i required for excitation-contraction coupling in cardiomyoctyes.
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ElectrophysiologyBackground
The phosphoinositide 3-kinases (PI3K) are a conserved
family of signal transduction enzymes that are involved
in regulating cellular proliferation and survival [1,2]. The
PI3Ks and the downstream serine/threonine kinase Akt
(also known as protein kinase B; PKB) regulate cellular
activation, inflammatory responses, chemotaxis and
apoptosis [1]. We [3] and others [4] have demonstrated
that activation of PI3K/Akt dependent signaling attenu-
ates the pro-inflammatory phenotype and increases sur-
vival outcome in sepsis. We have also reported that
sepsis decreases myocardial Akt activation [5], which
correlates with cardiac dysfunction in sepsis. In the same* Correspondence: wonderge@etsu.edu
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reproduction in any medium, provided the orreport, we demonstrated that preventing sepsis-induced
changes in myocardial Akt activation correlates with
prevention of cardiac dysfunction [5].
PI3K/Akt/PKB may play a role in cardiomyocyte cal-
cium regulation; however, the precise mechanisms by
which this occurs have not been fully elucidated. Yano
and colleagues employed a transgenic mouse model
over-expressing PI3K p110α in the heart [6], which
resulted in increased left ventricular pressure, increased
levels of L-type Ca2+ channels, ryanodine receptors and
sarcoplasmic reticulum Ca2+-ATPase 2a [6]. In a subse-
quent report, Lu et al. demonstrated that genetic abla-
tion of PI3K p110α resulted in reduced numbers of
voltage-dependent L-type Ca2+ channels in isolated car-
diomyocytes, reduced inward Ca2+ current and a defect
in contractile function [7]. Taken together the results
above indicate that PI3k/Akt signaling plays a critical
role in normal cardiac function and in maintainingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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likely involves regulation of cellular calcium.
We conducted the present study to determine whether
direct inhibition of the PI3K, PI3K-specific isoforms or
Akt-PKB signaling in HL-1 cardiomyocytes alters cal-
cium regulation. HL-1 is a proliferating atrial myocyte
cell line established from a subcutaneous tumor of AT-1
cells that, in turn, were derived from the atria of a mouse
transgenic for the simian virus 40 large T antigen under
control of the atrial natriuretic factor promoter [8,9].
These cells display spontaneous contractions in tissue
culture, oscillations of [Ca2+]i, and express functional L-
and T-type Ca2+ channels [10]. HL-1 cells also express
the PI3K/Akt-PKB signaling pathway, which mediates
interleukin-18 induced cellular hypertrophy [11]. Herein,
we report that inhibitors of PI3K/Akt-PKB decrease [Ca2+],
diminish Ca2+ transients and inhibit membrane Ca2+
currents, ICa, in these murine cardiomyocytes. These data




HL-1 atrial cardiomyocytes were a gift of Dr. William
Claycomb (Louisiana State University Medical Center).
They were grown in 5% CO2 at 37 °C in Claycomb
media (Sigma) supplemented with batch specific 10%
FBS (Sigma), 100 U/ml:100 μg/ml Penicillin/Strepto-
mycin (Invitrogen), 0.1 mM norepinephrine (Sigma) and
2 mM L-glutamine (Invitrogen). Before culturing cells,
flasks were treated overnight with 0.02% Bacto© gelatin
(Fisher Scientific):0.5% Fibronectin (Invitrogen). For
electrophysiologic or calcium measurements cells were
plated at a density of 3X105 cells/35-mm culture dish on
glass cover slips (12 mm diameter), which had been
flamed briefly to enhance coating and then transferred
to a 35-mm culture dish where they were treated with
gelatin/fibronectin overnight.
Whole-cell voltage clamp measurements
Cells were grown for 1–2 days on 12-mm diameter glass
plastic coverslips, which were transferred to an acrylic
chamber (Warner, New Haven, CT) on the stage of an
inverted microscope (Olympus IMT-2) equipped with
Hoffman modulation contrast optics. Cells were superfused
at room temperature with a standard external salt solution.
Patch pipettes (3–6 MΩ in the bath solution) were fabri-
cated from glass capillaries (1.1-1.2 mm ID, 0.2 mm wall
thickness, non-heparinized micro-hematocrit capillary
tubes; Fisher Scientific) with a Brown-Flaming horizontal
micropipette puller (P-97, Sutter Instruments, Novato, CA).
A micromanipulator (MO-202, Narishige, Tokyo) fixed to
the microscope was used to position pipettes. The whole-
cell patch configurations were obtained by standard patchclamp technique [12]. Voltage-clamp currents were mea-
sured with a patch clamp amplifier (Axopatch 200B, Axon
Instruments, Foster City, CA) with the lowpass, Bessell fil-
tering (−3 dB) set at 5 kHz. Signals from the patch clamp
amplifier were fed into a computer via a digital interface
(Digidata 1322A) and processed by Clampex 8 software
(Axon Instruments). Ag/AgCl half-cells constituted the
electrodes, and agar bridges (4% w v-1 in external solution)
connected the reference electrodes to the bath solution.
Series resistances were compensated following whole-cell
access prior to recordings. Giga-ohm seals between pipettes
and cell membranes were made with cells perfused with
standard external solution. For ICa measurements the cells
were perfused with an external solution in which an imper-
meable cation was substituted for Na+, and Ca2+ concentra-
tion was increased (below).
Intracellular Ca2+ measurements
Cells were loaded with Fura-2/AM (TefLabs, Austin,
TX) by incubating them for 30 min at room temperature
(22–23 °C) with a standard external salt solution con-
taining 2-μM Fura-2/AM. Cells were then washed with
the external salt solution and incubated at 37 °C with 5%
CO2 for 30 min in the supplemented Claycomb media.
The coverslip was transferred to an acrylic chamber
(Warner Instr. Co., Hamden, CT) on the microscope
stage and washed with the external salt solution for
5 minutes before measurements. Temperature was
maintained throughout measurements at 37 °C by a
stage/inline temperature controller (Warner Instr. Co.,
Hamden, CT) Fluorescence was measured with an im-
aging system consisting of a xenon fiberoptic light
source (Perkin-Elmer, Waltham, MA), a filter wheel and
a Basler A311F VGA Camera connected to an Olympus
IX71inverted fluorescence microscope. The filter wheel
and data acquisition were controlled by the InCyte2 soft-
ware (v. 5.29; Intracellular Imaging, Cincinnati, OH).
[Ca2+] was determined by interpolation from a standard
curve generated by Ca2+ calibration buffer kit #2 (Mo-
lecular Probes @ Life Technologies, Grand Island, NY)
and Fura-2/K5-salt. After correction for the individual
background fluorescence, the ratio of the fluorescence at
both excitation wavelengths (F340/F380) was monitored
simultaneously in 30–40 cells, identified by their fluores-
cence within a single view field. Images were collected
every 3.3 s. Each slide was perfused with standard exter-
nal salt solution for 6 min for control measurements,
followed by 10 min with the experimental solution. At
16 min, the slide was washed with standard external salt
solution for 5 min, and at 21 min data collection was
stopped. Data was then exported to MS Excel and
graphed using Origin 7.0 (OriginLab Corp., Northamp-
ton, MA) and Sigmaplot 11.0 (Systat Software, Inc.,
Chicago, IL). For statistical analyses, average [Ca2+]i
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obtained during the control period of 1–5 min from
each of 5 separate HL-1 cell preparations. These
averages were then compiled to obtain average control
values (n = 5), and comparisons were made on data col-
lected similarly from the same microscopic fields 15 min-
utes after experimental additions. Statistical differences
between control and experimental values were estab-
lished at p< 0.05 (Student’s paired T-test).
Solutions and chemicals
Standard external salt solution contained (mM): NaCl 150,
KCl 6, MgCl2 1, CaCl2 1.5, N-2-Hydroxyethylpiperazine
-N’-2-ethanesulfonic acid (HEPES) 10, glucose 10 (pH
adjusted to 7.41 with NaOH). Pipette solution contained
(mM): potassium aspartate 120, Na2GTP 0.4, Na2ATP 5,
MgCl2 1, EGTA 5, CaCl2 0.1, HEPES 10 (pH adjusted to
7.2 with KOH). For whole-cell voltage clamp measurements
of membrane Ca2+ currents external NaCl was substituted
with (mM) n-methy-D-gluamine chloride (NMDG+) 150,
and CaCl2 was increased to 5 to maximize Ca
2+ current. All
solution constituents were obtained from Sigma/Aldrich,
St. Louis, MO.
LY 294002 was obtained from Alomone Labs, LTD, Je-
rusalem, Israel. The PI3 kinase isoform inhibitors: PI3-
kinase α inhibitor 2, TGX-221 β inhibitor, AS-252424 γ
isoform inhibitor; and the AKT inhibitor, Triciribine
were obtained from Cayman Chemical, Ann Arbor, MI.
The dosages selected for the various inhibitors were
based on the literature and the manufacturer’s instruc-
tions. All inhibitors were dissolved in DMSO in stock
solutions and then diluted to final concentration. The
highest final concentration of DMSO by this approach
was 0.24% DMSO.
Results
Pharmacologic inhibition of PI3K significantly reduces
[Ca2+]i, and Ca
2+ transients in HL-1 cardiomyocytes
Action potentials and corresponding spontaneous transi-
ents in intracellular Ca2+, [Ca2+]i, occur in approximately
40% of non-confluent immortalized mouse HL-1 cardio-
myocytes [13,14]. Synchronous Ca2+ transients in three
such cells are shown in Figure 1A. Perfusing the cells
with LY 294002 (20 μM), a potent inhibitor of
phosphoinositde-3-kinases (PI3Ks), inhibited Ca2+ tran-
sients within 2 minutes, and this effect was partially
reversed on washout. When all cells within a micro-
scopic field (n = 37), i.e. those showing Ca2+ transients
and those without transients, were included in the com-
putation of mean [Ca2+]i, the Ca
2+ transients again were
evident, but the averaging reduced their magnitude,
Figure 1B. LY 294002 again abolished the Ca2+ transients
and diminished total [Ca2+]i, Figure 1B. Washout
restored total [Ca2+]i, but the Ca
2+ transients were nolonger apparent, except for partial restoration in 3 cells
out of the 10 of 37 cells showing Ca2+ transients (results
not shown). LY 294002 at 1 μM also inhibited Ca2+ tran-
sients with some restoration on washout, Figure 1C. LY
294002 at 1 μM also significantly reduced total [Ca2+]i,
Table 1, with modest but insignificant reversal on wash-
out within 5 minutes, Figure 1D. Surprisingly, 10-μM LY
294002 inhibition was insignificant. We attribute this in-
consistency to the variation in differentiated phenotype
among the population of HL-1 cells within a micro-
scopic field. The dynamic response of [Ca2+]i depends
on Ca2+ oscillations [14], which in turn depend on the If,
whose phenotype varies in these cells [13] .
Inhibition of PI3K isoforms and akt significantly reduces
[Ca2+]i, ICa and Ca
2+ transients in HL-1 cardiomyocytes
Considering that LY 294002 is a broad spectrum inhibitor
of PI3Ks and binds to various targets [15], we performed
measurements to determine whether inhibitors of specific
PI3K isoforms (i.e. α, β and γ) have similar effects on Ca2+
transients and total [Ca2+]i. PI3-kinase α inhibitor 2 (2 nM)
abolished Ca2+ transients in HL-1 cells within 3 to 4 min,
Figure 2A, with no reversal on washout. It also significantly
reduced total HL-1 [Ca2+]i, Table 2 and Figure 2B. Identical
effects were obtained for the PI3K β inhibitor (TGX-221,
100 nM), Figures 3A & 3B and Table 3, as well as for the
PI3K γ inhibitor (AS-252424, 100 nM), Figures 4A & 4B
and Table 3. A major downstream target of PI3K is Akt/
PKB [16]. Therefore, we pharmacologically inhibited Akt
in order to determine if the effect of PI3K on myo-
cardial [Ca2+]i is mediated via Akt. Triciribine (10 μM),
a specific inhibitor of Akt, also inhibited Ca2+ transients in
HL-1 cells with modest reversal of this inhibition on wash-
out, Figure 5A. Triciribine also significantly decreased HL-1
cell total [Ca2+]i, and this did not reverse on washout,
Table 4 and Figure 5B. DMSO (0.24%), the diluent used for
these inhibitors, had no effect on [Ca2+]i = 125.3± 7.2 nM
compared with Control [Ca2+]i = 131.6± 7.9 nM (p=0.18;
n=5).
Pharmacologic inhibition of PI3K and Akt significantly
reduces ICa
As an initial step to determine whether the effects by
inhibitors of PI3Ks and of Akt on Ca2+ transients and
total [Ca2+]i resulted from inhibition of membrane Ca
2+
channels, we determined the effect of LY 294002 and
triciribine on membrane Ca2+ currents in HL-1 cells.
For these measurements the pipette-membrane giga-
ohm seal and whole-cell access were obtained with cells
perfused with standard external solution. Once achieved,
the external solution was exchanged to one in which Na+
was substituted with NMDG+ and [Ca2+]o increased from
1.5 to 5 mM. Following 5-min equilibration, voltage clamp
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Figure 1 Phosphoinositide-3-kinase (PI3K) inhibition decreases intracellular Ca2+, [Ca2+]i, in HL-1 cell mouse cardiomyocytes. A. Effect of
LY294002 (20 μM) on oscillations of [Ca2+]i in three HL-1 cells showing synchronous oscillations of [Ca2+]i. B. Effect of LY294002 (20 μM) on
average [Ca2+]i in cells displaying oscillating and non-oscillating [Ca
2+]i (mean± SEM; n = 37 cells). C. Effect of LY294002 (1 μM) on [Ca
2+]i
oscillations in five representative HL-1 cells. Time base applies to all traces. D. Effect of LY294002 (1 μM) on average [Ca2+]i in cells displaying
oscillating and non-oscillating [Ca2+]i (mean± SEM; n = 5, each an average of 25 to 40 cells as shown in C).
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current, Figure 6A inset, under control conditions and fol-
lowing five minutes of an inhibitor of either PI3Ks or Akt.
The holding potential throughout these measurements was
−50 mV. Depolarizing voltage steps activated inward
current at~−40 mV, with maximal inward current occur-
ring with depolarizations ranging from −10 to 20 mV,Table 1 Effect of phosphoinositide-3-kinase inhibitor LY 2940





LY 294002 141.6 ± 10.1
(1 μM)
PI3K
LY 294002 160.6 ± 24.4
(10 μM)
PI3K
LY 294002 132.6 ± 5.2
(20 μM)
PI3K
Mean± SEM (n= 3 or 5 experiments each, with each experiment comprising the aveFigures 6A and 6B. The voltage-activated inward currents
were inhibited completely by perfusing the cells for 5 min
with either LY 294002 (10 μM), Figure 6A, or with triciri-
bine (10 μM), Figure 6B. Inward currents also were com-
pletely abolished by perfusing the cells with external
solution in which NMDG+ substituted for both Na+ and
Ca2+ (results not shown).02 on intracellular Ca2+ concentration recorded
Inhibitor (15 min) P value for difference
[Ca2+]i, (nM)
124.9 ± 6.9 <0.03
134.8 ± 12.0 =0.29
117.1 ± 6.1 <0.003




































PI3K  inhib. 2 (2 nM)
0 5 10 15 20 25
0
Time (min) 
Figure 2 Pharmacologic inhibition of phosphoinositide-3-kinase (PI3K) isoform α inhibitor decreased Ca2+, [Ca2+]i, in HL-1 cell mouse
cardiomyocytes. A. Effect of PI3K α inhibitor 2 (2 nM) on [Ca2+]i oscillations in five representative HL-1 cells. Time base applies to all traces. B.
Effect of PI3K α inhibitor 2 (2 nM) on average [Ca2+]i in cells displaying oscillating and non-oscillating [Ca2+]i (mean± SEM; n = 5, each an average
of 25 to 40 cells as shown in A).
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These findings show that PI3K/Akt-PKB signaling path-
ways play a significant role in regulating intracellular
Ca2+ in HL-1 cells, which constitute a murine-derived,
immortalized cell line with phenotypes like those of
adult cardiomyocytes [8,9]. We found that LY 294002, a
specific inhibitor of PI3K, as well as specific inhibitors of
each of the PI3K isoforms, i.e. α, β and γ catalytic PI3K
subunits, and an inhibitor of Akt/PKB, significantly
decreased [Ca2+]i and abolished Ca
2+ transients or oscil-
lations. Moreover, inhibition of PI3K/Akt-PKB signaling
pathways abolished inward Ca2+ current in the HL-1
cells, which likely results from L-type Ca2+ channels in
HL-1 cells.
Taken together we conclude that the PI3K/Akt-PKB
signaling pathway plays a role in sustaining the voltage-
activated Ca2+ current contributing to the HL-1 cell
action potential. Catalucci et al. [17] have shown that
Akt-dependent phosphorylation of Cavβ2, the chaperone
of the L-type Ca2+ channel pore-forming subunit, Cavα1,Table 2 Effect of phosphoinositide-3-kinase α inhibitor on int





PI3K α inhibitor 2 136.4 ± 8.6
(2 nM)
α
PI3K α inhibitor 2 114.9 ± 4.3
(4 nM)
α
PI3K α inhibitor 2 131.7 ± 9.0
(8 nM)
α
Mean± SEM (n= 5 experiments each, with each experiment comprising the averageantagonizes Cavα1 degradation and, as such, stabilizes
the functional channel in the plasma membrane. Inward
Ca2+ currents from action potential, via voltage-activated
membrane Ca2+ channels, induce Ca2+ release from the
sarcoplasmic reticulum [18,19], which accounts for
excitation-contraction coupling in cardiomyocytes [20].
We observed a two- to five-minute delay for various
PIK3/Akt-PKB inhibitors to reduce Ca2+ transients, [Ca2+]i
and ICa. This is consistent with a time course for the mani-
festation of inhibition of an enzymatic signaling cascade.
We conclude also that this delay is inconsistent with a dir-
ect inhibition of membrane Ca2+ channels by the various
inhibitors, which most likely would occur faster. The
marked reduction of ICa by PI3K/Akt-PKB inhibitors likely
results from diminution of L-type ICa. We cannot rule out
involvement of T-type ICa since both are expressed in HL-1
cells [10]. However, based upon our holding potential of
−50 mV compared with the more electronegative activating
voltages for T-type Ca2+ channels [10] and the relatively
extended time course of our ICa, the effects measured hereracellular Ca2+ concentration recorded 15 minutes after
Inhibitor (15 min) P value for difference
[Ca2+]i, (nM)
118.3 ± 5.9 <0.02
102.1 ± 2.5 <0.01
110.5 ± 4.7 =0.06








































Figure 3 Pharmacologic inhibition of phosphoinositide-3-kinase (PI3K) isoform β decreased Ca2+, [Ca2+]i, in HL-1 cell mouse
cardiomyocytes. A. Effect of TGX-221 (100 nM) on [Ca2+]i oscillations in five representative HL-1 cells. Time base applies to all traces. B. Effect of
TGX-221 (100 nM) on average [Ca2+]i in cells displaying oscillating and non-oscillating [Ca
2+]i (mean± SEM; n = 5, each an average of 25 to 40
cells as shown in A).
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large outward currents seen in the I/V plots at potentials
>30 mV result from K+ currents whose magnitude we have
found to vary considerably among HL-1 cells in non-
confluent culture (Wondergem, unpublished observations).
These findings also have implications for our under-
standing of the role of PI3K/Akt-PKB signaling in dis-
ease. As noted above, we have reported that sepsis
results in decreased activation of the PI3K/Akt pathway
in the myocardium [5]. We have also discovered that
constitutive up regulation of PI3K p110α in the myocar-
dium prevents sepsis induced cardiac dysfunction and
improves survival outcome in septic mice (Li, Williams
and colleagues, unpublished observations). Although
PI3K/Akt-PKB inhibition in septic mice undoubtedly
leads to increased cytokine production in these animals
[3], the present findings also indicate that PI3K/Akt-PKB
inhibition directly decreases availability of Ca2+ in the
mouse cardiomyocytes. Consistent with this conclusion
are the reports that ventricular myocytes obtained from
endotoxemic guinea-pigs [21] and septic pigs [22] show
marked reduction in L-type calcium current; whereas,
Akt/PKB overexpression in transgenic mice results in car-
diac hypertrophy, increased amplitude of Ca2+ transientsTable 3 Effect of phosphoinositide-3-kinases β and γ inhibito





TGX-221 105.5 ± 5.0
(100 nM)
β
AS-252424 121.8 ± 4.3
(100 nM)
γ
Mean± SEM (n= 5 experiments each, with each experiment comprising the averageand enhanced L-type membrane Ca2+ currents [23].
Lipopolysaccharide treatment of rats also leads to arrhyth-
mogenesis attributable to reduced mRNA levels encoding
for L-type Ca2+ subunits [24]. We reported that LPS dir-
ectly reduces Ca2+ transients in HL-1 cells; however, LPS
has no direct effect on L-type Ca2+ currents in these cells,
acting instead to reduce the funny current, If, [14] as also
shown by others [25]. Thus, to whatever extent sepsis
reduces cardiomyocyte [Ca2+]i and Ca
2+ transients by in-
hibition of PI3K/Akt-PKB, elevated cytokines most likely
effect these reductions and not LPS directly. On the other
hand, the present findings suggest that the amelioration of
sepsis and endotoxemia by preconditioning [26] or ische-
mia [27] may result from upregulation of the PK3/Akt-
PKB signaling pathways [3,28-32], which directly increases
[Ca2+]i available for excitation-contraction coupling in
cardiomyocytes.
All PI3K/Akt-PKB inhibitors used in these experiments
inhibited Ca2+ transients and significantly decreased [Ca2+]i;
however, we cannot attribute the importance of one
inhibitor over and against that of the others. Similar
inhibition Ca2+ transients and [Ca2+]i by LY294002 at either
20- or 1-μM rules out toxicity by the drug. Still, there is
considerable variability among HL-1 cells regarding thers on intracellular Ca2+ concentration recorded
Inhibitor (15 min) P value for difference
[Ca2+]i, (nM)
96.6 ± 4.8 <0.03
111.9 ± 6.0 <0.03
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Figure 4 Pharmacologic inhibition of phosphoinositide-3-kinase (PI3K) isoform γ decreases Ca2+, [Ca2+]i, in HL-1 cell mouse
cardiomyocytes. A. Effect of AS-252424 (100 nM) on [Ca2+]i oscillations in five representative HL-1 cells. Time base applies to all traces. B. Effect
of AS-252424 (100 nM) on average [Ca2+]i in cells displaying oscillating and non-oscillating [Ca
2+]i (mean± SEM; n = 5, each an average of 25 to 40










































Figure 5 Akt-PKB inhibition with triciribine decreases Ca2+, [Ca2+]i, in HL-1 cell mouse cardiomyocytes. A. Effect of triciribine (10 μM) on
[Ca2+]i oscillations in five representative HL-1 cells. Time base applies to all traces. B. Effect of triciribine (10 μM) on average [Ca2+]i in cells
displaying oscillating and non-oscillating [Ca2+]i (mean± SEM; n = 5, each an average of 25 to 40 cells as shown in A).
Table 4 Effect of Akt-PKB inhibitor on intracellular Ca2+ concentration recorded 15 minutes after addition of
respective inhibitors





Triciribine 177.4 ± 5.2 157.7 ± 1.9 <0.05
(1 μM)
Akt-PKB
Triciribine 125.7 ± 4.4 104.6 ± 4.8 <0.03
(10 μM)
Akt-PKB
Triciribine 216.8 ± 4.1 203.9 ± 1.4 =0.13
(20 μM)
Akt-PKB
Mean± SEM (n= 3 or 5 experiments each, with each experiment comprising the average [Ca2+] of 25 to 40 cells).


















































Figure 6 Pharmacologic inhibition of phosphoinositide-3-kinase
(PI3K) and Akt-PKB decrease Ca2+ current in HL-1 cell mouse
cardiomyocytes. A. Effect of LY294002 (10 μM) on I/V plot of Ca2+
current compared with control (mean± SEM; n = 3). Holding
potential =−50 mV. Inset. Overlay of currents recorded in same cell
before and after LY294002 (10 μM) during a voltage step from
−50 mV (HP) to 0 mV. Baseline current at −50 mV prior to voltage
step to 0 mV was 0 nA. B. Effect of triciribine (10 μM) on Ca2+
current compared with control (mean± SEM; n = 3). Holding
potential =−50 mV.
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We attribute this to variation in differentiated phenotype of
HL-1 cells 1–2 days after passage. While paired compari-
sons of the results between control and experimental condi-
tions clearly demonstrate effects of these inhibitors, the
variation of Ca2+ transients and [Ca2+]i among cells pre-
cludes analyses of the comparative effectiveness of the inhi-
bitors. We cannot readily account for Ca2+ variability
except to point out that these measurements were made on
single HL-1 cells or on small islands of multiple cells as
compared with confluent cell monolayers. Usually HL-1
cells require cell confluence following 3–4 days in culture
to fully establish the contracting phenotype [8,13], which
also suggests variable expression of ion channels needed for
this rhythmicity. As noted, we have observed marked vari-
ation in the magnitude of outward K+ currents in HL-1cells under these conditions. Indeed, we have been able to
elicit robust Ca2+ transients in otherwise quiescent cells by
perfusing the cells with an inhibitor of the delayed-rectifier
K+ channels (E-4031, 10 μM; Graves and Wondergem, un-
published observations); which are prevalent in HL-1 cells
[8,33]. Thus, variation among HL-1 cells in the strength of
repolarizing K+ current during action potentials or in cells
at rest may account for the different rates and amplitudes
of Ca2+ transients as well as [Ca2+]i.
Conclusions
In sum, we have found that inhibitors of the PI3K/Akt sig-
naling cascade decrease total [Ca2+]i, intracellular
Ca2+ transients and membrane ICa in a murine, immorta-
lized cardiomyocyte cell line, HL-1 cells. These data dem-
onstrate that PI3K/Akt dependent signaling is required for
normal Ca2+ metabolism in murine cardiomyocytes. This
extends our knowledge of the role of PI3K/Akt signaling in
cardiovascular homeostasis. We conclude that maintaining
myocardial PI3K/Akt signaling is essential for cardiomyo-
cyte function in the presence and absence of disease.Abbreviations
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